RDY DR REDDYS LABORATORIES LTD

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed May 18, 2026 Processed 26d 1h ago SEC 0001575872-26-000339
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
RDY ▲ +1.10% at T+5d
NEUTRAL call ✓ call won +1.10% · α vs SPY -0.52% · entry $13.60 → $13.75
Next anchor: T+20d in 3d
Currently $13.30 · -2.21% from $13.60 entry
Entry anchored
May 18, 2026
via day open
T+1d
-1.10%
call -1.10% · α -0.45%
$13.45
settled 25d ago
T+5d
+1.10%
call +1.10% · α -0.52%
$13.75
settled 18d ago
T+20d
call — · α —
in 3d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's Laboratories filed a 6-K furnishing a schedule of upcoming analyst/institutional investor meetings from May 20 to June 3, 2026, hosted by Elara Capital, Bank of America, Nomura, and Investec across Hong Kong, Singapore, Toronto, Boston, New York, and Princeton. This is a routine disclosure of non-deal roadshow activity with no material financial information, guidance, or operational updates.

Actionable Insight

This is a standard non-deal roadshow schedule with no material information. No trading action warranted. Monitor for any subsequent 6-K filings that may contain earnings results or business updates from these meetings.

Key Facts

  • Management will participate in investor meetings from May 20 to June 3, 2026
  • Meetings hosted by Elara Capital, Bank of America, Nomura, and Investec
  • All meetings are in-person group meetings across Hong Kong, Singapore, Toronto, Boston, New York, and Princeton
  • No financial results, guidance, or material business updates were disclosed

Financial Impact

No financial figures disclosed — routine investor relations activity with no quantifiable impact

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000339
Document: 0001575872-26-000339-index.html0001575872-26-000339
Document: 0001575872-26-000339.txt0001575872-26-000339
23 reports for RDY
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+5▲ +0.07%Feb 28, 2026
Filters
Rows
Reports for RDY — sortable, filterable
Type Now
Jun 10, 2026
2d ago
6-K
NEUTRAL ★ 2/10
$13.45 awaiting T+1awaiting T+1$13.30 (−1.08%)
Jun 5, 2026
7d ago
6-K
NEUTRAL ★ 2/10
$13.29 awaiting T+1awaiting T+1$13.30 (+0.11%)
Jun 3, 2026
10d ago
6-K
NEUTRAL ★ 2/10
$13.02 $13.24▲ +1.69%▲ +1.29%$13.30 (+2.15%)
Jun 1, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$13.26 $13.03▼ −1.73%▼ −1.88%$13.30 (+0.30%)
Jun 1, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$13.26 $13.03▼ −1.73%▼ −1.88%$13.30 (+0.30%)
May 29, 2026
14d ago
20-F
NEUTRAL ★ 2/10
$13.26 $13.03▼ −1.73%▼ −1.88%$13.30 (+0.30%)
May 28, 2026
15d ago
6-K
NEUTRAL ★ 2/10
$13.52 $13.63▲ +0.81%▲ +0.57%$13.30 (−1.63%)
May 28, 2026
16d ago
6-K
NEUTRAL ★ 2/10
$13.52 $13.63▲ +0.81%▲ +0.57%$13.30 (−1.63%)
May 18, 2026
25d ago
6-K
NEUTRAL ★ 2/10
$13.60 $13.45▼ −1.10%▼ −0.45%$13.30 (−2.21%)
May 18, 2026
26d ago
6-K
NEUTRAL ★ 2/10
$13.60 $13.45▼ −1.10%▼ −0.45%$13.30 (−2.21%)
Showing 10 of 23

US Market Status

Market Closed — Opens Mon (48h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access